Cheng, S. (2025) “Cardiotoxicity in low-to-moderate cardiovascular risk patients undergoing anti-HER2 therapy: A prospective CMR study”, Radiology and Oncology, 59(4), pp. 510–521. Available at: https://www.radioloncol.com/index.php/ro/article/view/4626 (Accessed: 17 April 2026).